Results 161 to 170 of about 2,538,825 (248)

Long-Term Outcome of Myocardial Protection in Heart Transplantation: Comparison Among 3 Different Solutions. [PDF]

Interdiscip Cardiovasc Thorac Surg
Settepani F, Cannata A, Belluschi I, Pisani GP, Mondino MG, Garascia A, Russo CF.   +6 more
europepmc   +1 more source

Functional annotation map of natural compounds in traditional Chinese medicines library: TCMs with myocardial protection as a case. [PDF]

Acta Pharm Sin B, 2023
Xing X, Sun M, Guo Z, Zhao Y, Cai Y, Zhou P, Wang H, Gao W, Li P, Yang H.   +9 more
europepmc   +1 more source

Nonmelanoma Skin Cancer Risk With JAK Inhibitors Compared to Interleukin‐6 Receptor Inhibitors in Rheumatoid Arthritis: Results From a National Cohort Study

Arthritis &Rheumatology, EarlyView.
Objective Nonmelanoma skin cancer (NMSC) is one of the most common malignancies in rheumatoid arthritis (RA). This analysis assessed NMSC risk with JAK inhibitors (JAKi) compared to interleukin‐6 receptor inhibitors (IL‐6Ri). Methods This study used data from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis linked to the
Zixing Tian, Lianne Kearsley‐Fleet, Sizheng Steven Zhao, James Galloway, Mark Lunt, Kath Watson, Narges Azadbakht, British Society for Rheumatology Biologics Register in Rheumatoid Arthritis Contributors Group, Kimme L. Hyrich   +8 more
wiley   +1 more source

Myocardial Protection Efficacy of Custodiol, Del Nido, and Cold Intermittent Blood Cardioplegia in Arterial Switch Operation. [PDF]

Interdiscip Cardiovasc Thorac Surg
Avşar MK, Güzel Y, Kırat B, Önsel İÖ, Zeybek C, Yorgancılar D, Yücel İK.   +6 more
europepmc   +1 more source

Effects of swimming training on myocardial protection in rats. [PDF]

Biomed Rep, 2022
Lai CC, Tang CY, Fu SK, Tseng WC, Tseng KW.   +4 more
europepmc   +1 more source

Deucravacitinib in Active Psoriatic Arthritis: Efficacy and Safety up to 52 Weeks From the Randomized, Double‐Blind, Phase 3 POETYK PsA‐2 Trial

Arthritis &Rheumatology, Accepted Article.
Objective To assess the efficacy and safety of deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, in patients with psoriatic arthritis (PsA) who were naive to biologic disease‐modifying antirheumatic drugs or received tumor necrosis factor inhibitors. Methods In the 52‐week (W), double‐blind, placebo‐controlled, phase 3 POETYK PsA‐2 study
Philip J. Mease, Vinod Chandran, April W. Armstrong, Ricardo Blanco, Alexis Ogdie, Evan L. Siegel, Alice B. Gottlieb, Xiaofeng Zeng, Diamant Thaçi, Mitsumasa Kishimoto, Hendrik Schulze‐Koops, Alan Kivitz, Eva Dokoupilová, Akimichi Morita, Eric M. Ruderman, Michael Plewinski, Kejia Wang, Caroline Sardinas, Eleni Vritzali, John Vaile, Atul Deodhar   +20 more
wiley   +1 more source

Myocardial protection by adenosine triphosphate-sensitive potassium channel opener diazoxide involves sulfonylurea receptor 2 subunit. [PDF]

JTCVS Open
Wang J, Bradshaw A, Tryon R, Pan R, Holmes SD, Nichols C, Lawton JS.   +6 more
europepmc   +1 more source

Expert Perspective: Toward Treat‐to‐Target Management in Adult Idiopathic Inflammatory Myopathies

Arthritis &Rheumatology, Accepted Article.
Treat‐to‐target (T2T) has transformed the management of several rheumatic diseases through predefined therapeutic goals, structured disease assessment, and timely treatment adjustment. Despite major advances in the understanding and treatment of idiopathic inflammatory myopathies (IIM), a formal T2T framework for adult IIM has not yet been established.
Shiri Keret, Nantakarn Pongtarakulpanit, Rohit Aggarwal   +2 more
wiley   +1 more source

Comparison of the effect of cardioplegic solutions used in cardiac surgery on myocardial protection. [PDF]

Rev Assoc Med Bras (1992)
Padak M, Dikme R, Ersöz E, Hacanlı Y.
europepmc   +1 more source

Myocardial protection of S-nitroso-L-cysteine in diabetic cardiomyopathy mice. [PDF]

Front Endocrinol (Lausanne), 2022
Peng L, Zhu M, Huo S, Shi W, Jiang T, Peng D, Wang M, Jiang Y, Guo J, Men L, Huang B, Wang Q, Lv J, Lin L, Li S.   +14 more
europepmc   +1 more source